2H-1,2,4-Benzothiadiazine-7-sulfonamide,3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide cas no:73-48-3
Synonyms: 2H-1,2,4-Benzothiadiazine-7-sulfonamide,3-benzyl-3,4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide (6CI,8CI);3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide1,1-dioxide;3-Benzyl-6-trifluoromethyl-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine1,1-dioxide;6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide;Aprinox;Be 724A;Bendrofluazide;Bentride;Benuron;Benzy-Rodiuran;Berkozide;Bristuron;Centyl;FT 81;Livesan;Naigaril;Naturetin;Neo-Rontyl;Niagaril;Orsile;Pluryl;Pluryle;Poliuron;Rauzide;Relan Beta;Salural;Sinesalin;Sodiuretic;Urlea;
Name2H-1,2,4-Benzothiadiazine-7-sulfonamide,3,4-dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-dioxide
CAS73-48-3
Synonyms2H-1,2,4-Benzothiadiazine-7-sulfonamide,3-benzyl-3,4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide (6CI,8CI);3-Benzyl-3,4-dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide1,1-dioxide;3-Benzyl-6-trifluoromethyl-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine1,1-dioxide;6-Trifluoromethyl-3-benzyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide;Aprinox;Be 724A;Bendrofluazide;Bentride;Benuron;Benzy-Rodiuran;Berkozide;Bristuron;Centyl;FT 81;Livesan;Naigaril;Naturetin;Neo-Rontyl;Niagaril;Orsile;Pluryl;Pluryle;Poliuron;Rauzide;Relan Beta;Salural;Sinesalin;Sodiuretic;Urlea;
EINECS(EC#)200-800-1
Molecular FormulaC15H14F3N3O4S2
Molecular Weight421.44
Appearancewhite solid
refractive index1.583
storage tempRefrigerator
Safety
Poison by intravenous route. Human systemic effects by ingestion: convulsions and somnolence. Mutation data reported. When heated to decomposition it emits toxic fumes of F−, SOx, and NOx.
| Organism |
Test Type |
Route |
Reported Dose (Normalized Dose) |
Effect |
Source |
| mouse |
LD50 |
intraperitoneal |
4800mg/kg (4800mg/kg) |
|
Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. Vol. 238, Pg. 435, 1960. |
| mouse |
LD50 |
intravenous |
395mg/kg (395mg/kg) |
PERIPHERAL NERVE AND SENSATION: SPASTIC PARALYSIS WITH OR WITHOUT SENSORY CHANGE
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Journal of Pharmacology and Experimental Therapeutics. Vol. 134, Pg. 273, 1961. |
| mouse |
LD50 |
oral |
> 10gm/kg (10000mg/kg) |
|
Drugs in Japan Vol. 6, Pg. 781, 1982. |
| women |
TDLo |
oral |
300ug/kg/3D-I (0.3mg/kg) |
|
Lancet. Vol. 2, Pg. 634, 1986. |
